These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34494727)

  • 1. Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening.
    Fang G; Lu H; Rodriguez de la Fuente L; Law AMK; Lin G; Jin D; Gallego-Ortega D
    Adv Sci (Weinh); 2021 Nov; 8(21):e2102418. PubMed ID: 34494727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays.
    Brandenberg N; Hoehnel S; Kuttler F; Homicsko K; Ceroni C; Ringel T; Gjorevski N; Schwank G; Coukos G; Turcatti G; Lutolf MP
    Nat Biomed Eng; 2020 Sep; 4(9):863-874. PubMed ID: 32514094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol to encapsulate cerebral organoids with alginate hydrogel shell to induce volumetric compression.
    Wang Z; Tang X; Khutsishvili D; Sang G; Galan EA; Wang J; Ma S
    STAR Protoc; 2024 Jun; 5(2):102952. PubMed ID: 38555589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forming Single-Cell-Derived Colon Cancer Organoid Arrays on a Microfluidic Chip for High Throughput Tumor Heterogeneity Analysis.
    Chen Z; Chen J; Lin D; Kang H; Luo Y; Wang X; Wang L; Liu D
    ACS Biomater Sci Eng; 2024 Aug; 10(8):5265-5273. PubMed ID: 39087916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery.
    Davoudi Z; Peroutka-Bigus N; Bellaire B; Jergens A; Wannemuehler M; Wang Q
    Mar Drugs; 2021 May; 19(5):. PubMed ID: 34065505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
    Duarte AA; Gogola E; Sachs N; Barazas M; Annunziato S; R de Ruiter J; Velds A; Blatter S; Houthuijzen JM; van de Ven M; Clevers H; Borst P; Jonkers J; Rottenberg S
    Nat Methods; 2018 Feb; 15(2):134-140. PubMed ID: 29256493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and long-term culture of mouse mammary stem cell organoids and breast tumor organoids.
    Cui J; Guo W
    STAR Protoc; 2021 Jun; 2(2):100577. PubMed ID: 34124696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
    Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
    STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.
    Sabhachandani P; Sarkar S; Mckenney S; Ravi D; Evens AM; Konry T
    J Control Release; 2019 Feb; 295():21-30. PubMed ID: 30550941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening.
    Chen MC; Gupta M; Cheung KC
    Biomed Microdevices; 2010 Aug; 12(4):647-54. PubMed ID: 20237849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
    Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
    Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Chips-in-Lab to Point-of-Care Live Cell Device: Development of a Microfluidic Device for On-Site Cell Culture and High-Throughput Drug Screening.
    Feng Y; Che B; Fu J; Sun Y; Ma W; Tian J; Dai L; Jing G; Zhao W; Sun D; Zhang C
    ACS Biomater Sci Eng; 2024 Aug; 10(8):5399-5408. PubMed ID: 39031055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Microfluidic Chip-Based Automated System for Whole-Course Monitoring the Drug Responses of Organoids.
    Zhang K; Xi J; Wang Y; Xue J; Li B; Huang Z; Zheng Z; Liang N; Wei Z
    Anal Chem; 2024 Jun; 96(24):10092-10101. PubMed ID: 38833634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
    Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
    Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screening in colorectal cancer tissue-originated spheroids.
    Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M
    Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.
    Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW
    Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing estrogen-responsive mouse mammary organoids from single Lgr5
    Zhang L; Adileh M; Martin ML; Klingler S; White J; Ma X; Howe LR; Brown AM; Kolesnick R
    Cell Signal; 2017 Jan; 29():41-51. PubMed ID: 27511963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
    Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
    J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
    Tan T; Mouradov D; Gibbs P; Sieber OM
    STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.